Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.930
-0.060 (-3.02%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Cibus Employees
As of December 31, 2024, Cibus had 159 total employees, including 157 full-time and 2 part-time employees. The number of employees decreased by 24 or -13.11% compared to the previous year.
Employees
159
Change (1Y)
-24
Growth (1Y)
-13.11%
Revenue / Employee
$26,805
Profits / Employee
-$1,581,057
Market Cap
66.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CBUS News
- 1 day ago - Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call - GlobeNewsWire
- 2 days ago - USDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not Regulated - GlobeNewsWire
- 5 weeks ago - Cibus, Inc. (CBUS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Cibus Reports Fourth Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward - GlobeNewsWire
- 6 weeks ago - Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call - GlobeNewsWire
- 7 weeks ago - Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola - GlobeNewsWire
- 2 months ago - Cibus Announces Leadership Change and CEO Succession Plan - GlobeNewsWire